Literature DB >> 26411663

Estimation of Prevalence and Incidence of Sexually Transmitted Infections in Iran; A model-based approach.

Maryam Nasirian1, Mohammd Reza Baneshi2, Kianoush Kamali3, Ali Akbar Haghdoost4.   

Abstract

BACKGROUND: Routine reporting of sexually transmitted infections (STIs) in Iran is one of the main information sources on STIs, endures some diminution under influence of several factors. We aimed to adjust registered STI data with a model-based approach and estimate the incidence and prevalence of STIs in Iran.
METHODS: In this cross-sectional study, we developed a stochastic compartmental model considering effects of influential factors on STI reporting process to adjust registered STI data. We reviewed literature and used Delphi method to collect data and estimate model parameters. We calibrated the model using Monte Carol simulation with 95% confidence interval (CI). Finally, we validated the models by comparing their output with investigational data.
RESULTS: The estimated prevalence of male urethral discharge was 0.40% (95% CI: 0.26%, 0.65%); the prevalence of genital ulcers was 3.68% (95% CI: 2.31%, 6.43%) in women and 0.16% (95% CI: 0.10%, 0.27%) in men. The estimated incidence for Neisseria gonorrhoeae, Chlamydia trachoma and syphilis per 1000 women was 2.44 (95% CI: 1.17, 6.65), 5.02 (95% CI: 2.78, 10.16) and 0.04 (95% CI: 0.02, 0.05) respectively; the corresponding figures per 1000 men were 0.43 (95% CI: 0.26, 0.80), 0.82 (95% CI: 0.42, 1.92) and 0.005 (95% CI: 0.003, 0.008).
CONCLUSIONS: Various factors are responsible for the obvious underestimation in the number of STIs registered in Iran. Notwithstanding this underestimation, our models offer an indirect method of estimating the prevalence of STIs in the country. Providing policymakers and STI experts with more realistic estimates might prompt policymakers and STI experts to recognize the importance of STIs in Iran and help them to develop appropriate prevention and control programs.

Entities:  

Keywords:  Adults; Epidemiology; Iran; Modeling; Prevalence; Sexually Transmitted Disease

Mesh:

Year:  2015        PMID: 26411663

Source DB:  PubMed          Journal:  J Res Health Sci        ISSN: 2228-7795


  6 in total

1.  Genital infections and reproductive complications associated with Trichomonas vaginalis, Neisseria gonorrhoeae, and Streptococcus agalactiae in women of Qom, central Iran.

Authors:  Mahmoud Nateghi Rostami; Batool Hossein Rashidi; Azam Habibi; Razieh Nazari; Masoumeh Dolati
Journal:  Int J Reprod Biomed       Date:  2017-06

2.  The Prevalence of Human Immunodeficiency Virus Infection in Patients with Sexually Transmitted Diseases.

Authors:  Mohammad Mahdi Majzoobi; Mohammad Reza Sobhan; Mehrangiz Zamani; Abbas Moradi; Sahar Khosravi; Ali Saadatmand
Journal:  Adv Biomed Res       Date:  2020-03-16

3.  Co-Infections and Sero-Prevalence of HIV, Syphilis, Hepatitis B and C Infections in Sexually Transmitted Infections Clinic Attendees of Tertiary Care Hospital in North India.

Authors:  Sonali Bhattar; Prabhav Aggarwal; Satyendra Kumar Sahani; Preena Bhalla
Journal:  J Res Health Sci       Date:  2016

4.  Prevalence of Symptom-based Sexually Transmitted Infections and Related Factors among Incarcerated Men in Iran, 2013.

Authors:  Armita Shahesmaeili; Mostafa Shokoohi; Fatemeh Tavakoli; Mohammad Hassan Rabiee; Kianoush Kamali; Ali Akbar Haghdoost; Mohammad Karamouzian; Hamid Sharifi
Journal:  Med J Islam Repub Iran       Date:  2021-12-29

5.  Educational interventions to improve women's preventive behavior of sexually transmitted infections (STIs): study protocol for a randomized controlled trial.

Authors:  Afsaneh Karami Juyani; Fatemeh Zarei; Shamsodin Niknami; Alireza Haydarni; Raziyeh Maasoumi
Journal:  Trials       Date:  2022-09-02       Impact factor: 2.728

6.  Narrative review of women's health in Iran: challenges and successes.

Authors:  Hassan Joulaei; Najmeh Maharlouei; Kamran Bagheri Lankarani; Alireza Razzaghi; Maryam Akbari
Journal:  Int J Equity Health       Date:  2016-02-16
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.